Paper26311337
MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.
Deiuliis JA. Int J Obes (Lond), 2016. Cited by 288 papers, by iCite.
Cite this record
ConductScience Library. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Papers, record 26311337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26311337
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Insulin Resistance | Major topic |
| Metabolic Syndrome | Major topic |
| MicroRNAs | Major topic |
| Molecular Targeted Therapy | Major topic |
| Obesity | Major topic |
| Adipogenesis | |
| Animals | |
| Biomarkers | |
| Disease Models, Animal | |
| Humans | |
| Lipid Metabolism | |
| Mice | |
| Prevalence | |
| Signal Transduction | |
| United States |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K01 DK099475 | NIDDK NIH HHS | United States | K01DK099475 | PubMed and NIH |
| K01DK099475 | NIDDK NIH HHS | United States | K01DK099475 | PubMed and NIH |
Source NIH RePORTER
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07917364 | Asprosin and miRNA Expression in Young Women With Metabolic Syndrome | Background |
Source ClinicalTrials.gov
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22012398 | Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. | Nature | 2011 | https://conductscience.org/library/papers/22012398 | PubMed |
| 2 | 24260478 | Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs. | PLoS One | 2013 | https://conductscience.org/library/papers/24260478 | PubMed |
| 3 | 21423178 | MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. | Nat Cell Biol | 2011 | https://conductscience.org/library/papers/21423178 | PubMed |
| 4 | 20661255 | The widespread regulation of microRNA biogenesis, function and decay. | Nat Rev Genet | 2010 | https://conductscience.org/library/papers/20661255 | PubMed |
| 5 | 8253716 | Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8253716 | PubMed |
| 6 | 24105413 | Autocrine role of interleukin-13 on skeletal muscle glucose metabolism in type 2 diabetic patients involves microRNA let-7. | Am J Physiol Endocrinol Metab | 2013 | https://conductscience.org/library/papers/24105413 | PubMed |
| 7 | 21646721 | Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21646721 | PubMed |
| 8 | 23729590 | Differential effects of maternal obesity and weight loss in the periconceptional period on the epigenetic regulation of hepatic insulin-signaling pathways in the offspring. | FASEB J | 2013 | https://conductscience.org/library/papers/23729590 | PubMed |
| 9 | 24333578 | MicroRNA-344 inhibits 3T3-L1 cell differentiation via targeting GSK3β of Wnt/β-catenin signaling pathway. | FEBS Lett | 2014 | https://conductscience.org/library/papers/24333578 | PubMed |
| 10 | 22580331 | A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. | Circulation | 2012 | https://conductscience.org/library/papers/22580331 | PubMed |
| 11 | 20216554 | MicroRNA control of signal transduction. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20216554 | PubMed |
| 12 | 19289822 | miR-375 maintains normal pancreatic alpha- and beta-cell mass. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19289822 | PubMed |
| 13 | 20198361 | Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. | Diabetologia | 2010 | https://conductscience.org/library/papers/20198361 | PubMed |
| 14 | 23399447 | miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. | Stem Cell Res | 2013 | https://conductscience.org/library/papers/23399447 | PubMed |
| 15 | 18824696 | The microRNA miR-8 is a conserved negative regulator of Wnt signaling. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18824696 | PubMed |
| 16 | 23756832 | Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α. | Diabetologia | 2013 | https://conductscience.org/library/papers/23756832 | PubMed |
| 17 | 23867206 | Decreased microRNA-221 is associated with high levels of TNF-α in human adipose tissue-derived mesenchymal stem cells from obese woman. | Cell Physiol Biochem | 2013 | https://conductscience.org/library/papers/23867206 | PubMed |
| 18 | 20466885 | MiR-33 contributes to the regulation of cholesterol homeostasis. | Science | 2010 | https://conductscience.org/library/papers/20466885 | PubMed |
| 19 | 24504735 | MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. | Arterioscler Thromb Vasc Biol | 2014 | https://conductscience.org/library/papers/24504735 | PubMed |
| 20 | 24478399 | Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. | Diabetes Care | 2014 | https://conductscience.org/library/papers/24478399 | PubMed |
Cited by196
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 288 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972590 | Emerging molecular and cellular therapeutics for type 2 diabetes: integrating stem cell and miRNA approaches toward precision medicine. | Stem Cell Res Ther | 2026 | https://conductscience.org/library/papers/42972590 | PubMed |
| 42877166 | lncRNA SNHG6 improves placental villous cell function in an in vitro model of gestational diabetes mellitus. | Arch Med Sci | 2026 | https://conductscience.org/library/papers/42877166 | PubMed |
| 42737456 | Endothelial Dysfunction and Obesity: New Diagnostic and Therapeutic Strategies. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737456 | PubMed |
| 42621662 | MicroRNAs as Key Regulators of Degeneration and Inflammation in Osteoarthritis: A Narrative Review. | Saudi J Med Med Sci | 2026 | https://conductscience.org/library/papers/42621662 | PubMed |
| 42511844 | MicroRNAs in Obesity, Insulin Resistance, and Type 2 Diabetes: Mechanistic Insights and Translational Perspectives. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511844 | PubMed |
| 42346030 | Longitudinal Analysis of Peripheral MicroRNA Expression and Depressive Symptom Severity Change in a Community Cohort. | Epigenomes | 2026 | https://conductscience.org/library/papers/42346030 | PubMed |
| 42344151 | Circulating miRNAs in pediatric obesity: a single-center exploratory study of their potential association with renal function. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42344151 | PubMed |
| 42074159 | Analysis of Circulating MicroRNAs in Patients with Diabetic Foot Ulcers and Lower Limb Amputation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074159 | PubMed |
| 41922729 | Dietary restriction and aerobic exercise alleviate obesity-related skeletal muscle impairment via the miR-130/PPARγ axis and IGF-1/Akt/mTOR signaling activation. | Sci Rep | 2026 | https://conductscience.org/library/papers/41922729 | PubMed |
| 41823133 | Super-enhancer-associated miR-1260b coordinates adipogenesis and metabolic programming in human adipose stem cells. | Adipocyte | 2026 | https://conductscience.org/library/papers/41823133 | PubMed |
| 41814054 | miR-128-3p and miR-223-3p as Potential Biomarkers of Metabolic Dysfunction in Liver Tissue from Patients Undergoing Metabolic Bariatric Surgery. | Obes Surg | 2026 | https://conductscience.org/library/papers/41814054 | PubMed |
| 41422161 | Extracellular vesicle microRNAs in breastmilk of mothers with overweight and obesity: a systematic review. | Pediatr Res | 2026 | https://conductscience.org/library/papers/41422161 | PubMed |
| 41351773 | Paternal transgenerational epigenetic effects: high fat diet induced obesity alters miRNA expression in F1 and F2 C57BL/6 male mice. | Mol Genet Genomics | 2025 | https://conductscience.org/library/papers/41351773 | PubMed |
| 41341137 | Exosomal miRNAs as potential biomarkers for insulin resistance and metabolic dysfunction-associated steatotic liver disease in children with obesity. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41341137 | PubMed |
| 41184616 | Molecular Genetics and Epigenetics Regulatory Role of miRNAs on Adipogenesis and Intramuscular Fat Development in Beef Cattle: In the Context of Meat Quality. | Mol Biotechnol | 2026 | https://conductscience.org/library/papers/41184616 | PubMed |
| 41032651 | Epigenetic Mechanisms in Childhood Obesity. | Ann N Y Acad Sci | 2025 | https://conductscience.org/library/papers/41032651 | PubMed |
| 40977960 | Regulatory Roles of MicroRNAs in Female and Male Human Reproduction: A Narrative Review. | Iran J Med Sci | 2025 | https://conductscience.org/library/papers/40977960 | PubMed |
| 40911641 | Charting the equine miRNA landscape: An integrated pipeline and browser for annotating, quantifying, and visualizing expression. | PLoS Genet | 2025 | https://conductscience.org/library/papers/40911641 | PubMed |
| 40787105 | Integrative analysis of DEGs and regulatory networks in T2DM: identification of core genes and regulatory elements as novel therapeutic targets. | 3 Biotech | 2025 | https://conductscience.org/library/papers/40787105 | PubMed |
| 40786421 | Elucidating the Role of MicroRNAs in Regulating Insulin Signaling Pathways: Implications for the Pathophysiology and Treatment of Type 2 Diabetes. | Cureus | 2025 | https://conductscience.org/library/papers/40786421 | PubMed |
Genes69
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26311337
GET https://conductscience.org/api/papers/v1/26311337/references?page=2